These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 38872625)
1. IRL790 modulated striatal D1 neurons synaptic plasticity ameliorating levodopa-induced dyskinesia in mouse. Wang X; Zhang W Front Aging Neurosci; 2024; 16():1401991. PubMed ID: 38872625 [TBL] [Abstract][Full Text] [Related]
2. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia. Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437 [TBL] [Abstract][Full Text] [Related]
3. Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia. Lanza K; Centner A; Coyle M; Del Priore I; Manfredsson FP; Bishop C Exp Neurol; 2021 Feb; 336():113534. PubMed ID: 33249031 [TBL] [Abstract][Full Text] [Related]
7. Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models. Thiele SL; Chen B; Lo C; Gertler TS; Warre R; Surmeier JD; Brotchie JM; Nash JE Neurobiol Dis; 2014 Nov; 71():334-44. PubMed ID: 25171793 [TBL] [Abstract][Full Text] [Related]
8. Differential Activation States of Direct Pathway Striatal Output Neurons during l-DOPA-Induced Dyskinesia Development. Figge DA; Amaral HO; Crim J; Cowell RM; Standaert DG; Eskow Jaunarajs KL J Neurosci; 2024 Jun; 44(26):. PubMed ID: 38664012 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia. Calabrese V; Di Maio A; Marino G; Cardinale A; Natale G; De Rosa A; Campanelli F; Mancini M; Napolitano F; Avallone L; Calabresi P; Usiello A; Ghiglieri V; Picconi B Front Aging Neurosci; 2020; 12():230. PubMed ID: 32848709 [TBL] [Abstract][Full Text] [Related]
10. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors. Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596 [TBL] [Abstract][Full Text] [Related]
12. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. Fanni S; Scheggi S; Rossi F; Tronci E; Traccis F; Stancampiano R; De Montis MG; Devoto P; Gambarana C; Bortolato M; Frau R; Carta M Neurobiol Dis; 2019 Jan; 121():120-130. PubMed ID: 30261284 [TBL] [Abstract][Full Text] [Related]
13. Striatal overexpression of β-arrestin2 counteracts L-dopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's disease rats. Zhang ZR; Zhang XR; Luan XQ; Wang XS; Wang WW; Wang XY; Shao B; Xie CL Neurochem Int; 2019 Dec; 131():104543. PubMed ID: 31491493 [TBL] [Abstract][Full Text] [Related]
14. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia. Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173 [TBL] [Abstract][Full Text] [Related]
16. Striatal Gα Goto S Front Cell Neurosci; 2017; 11():364. PubMed ID: 29201000 [TBL] [Abstract][Full Text] [Related]
17. Striatal D Gao S; Gao R; Yao L; Feng J; Liu W; Zhou Y; Zhang Q; Wang Y; Liu J Front Aging Neurosci; 2022; 14():783893. PubMed ID: 35185524 [TBL] [Abstract][Full Text] [Related]
18. Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia. Sugiyama K; Kuroiwa M; Shuto T; Ohnishi YN; Kawahara Y; Miyamoto Y; Fukuda T; Nishi A J Neurosci; 2021 Jul; 41(30):6388-6414. PubMed ID: 34131032 [TBL] [Abstract][Full Text] [Related]
19. Dopamine D3 Receptor Plasticity in Parkinson's Disease and L-DOPA-Induced Dyskinesia. Lanza K; Bishop C Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33808538 [TBL] [Abstract][Full Text] [Related]
20. Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease. Fiorentini C; Savoia P; Savoldi D; Barbon A; Missale C Neurobiol Dis; 2013 Jun; 54():339-48. PubMed ID: 23328768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]